Consortium

TU/e is a research university specialising in engineering science and technology, and is widely recognised for its interdisciplinary research environment and collaboration with industry and healthcare partners. The first Department of Biomedical Engineering in the NL conducts cutting-edge research in cardiovascular modelling, medical imaging, and related technologies.

TU/e serves as Project Coordinator, overseeing the project from the scientific and operational standpoints, with a focus on computational modelling research approaches, and leading the project’s communication, dissemination, and exploitation activities.

UM is an internationally oriented research university with important expertise in health sciences and clinical research. Its Faculty of Health, Medicine and Life Sciences is particularly active in cardiovascular research and translational medicine, helping to translate scientific discoveries into clinical practice.

UM leads research on circulation-level modelling of thrombosis, supporting the development of patient-specific models to predict thrombosis-related clinical outcomes.

UvA is one of Europe’s leading research universities, with internationally recognised expertise in computational science and data-driven modelling. Its Computational Science Lab focuses on advanced simulation techniques and multi-scale modelling. The university has extensive experience in interdisciplinary research combining physics, biology, and computer science.

UvA leads research on cell-level computational modelling of thrombus formation, to capture the microscopic processes involved in clot initiation and cellular interactions.

KU Leuven is one of Europe’s oldest and most prestigious universities, internationally recognised for its excellence in biomedical and clinical research. Its cardiovascular sciences research groups are highly active in thrombosis, haemostasis, and vascular biology. The university collaborates extensively with hospitals and international research networks.

KU Leuven contributes expertise in platelet biology and thrombosis mechanisms, supporting the translation of biological insights into computational modelling approaches.

Charité is one of Europe’s largest university hospitals and a leading centre for medical research and clinical innovation, combining expertise in cardiovascular medicine, medical imaging, and computational modelling. Charité’s interdisciplinary teams work at the interface between engineering, medicine, and clinical practice.

Charité supports computational modelling approaches describing thrombus formation and their clinical validation, ensuring the clinical relevance of the models developed in the project.

UCL  is a world-leading research university with outstanding expertise in engineering, biomedical sciences, and medical technologies. The Department of Mechanical Engineering conducts advanced research on fluid dynamics, bioengineering, and cardiovascular flows, while the associated Royal Free London NHS Foundation Trust is a major UK teaching hospital with expertise in vascular surgery, cardiovascular diseases, and translational clinical research.

UCL leads the doctoral training programme, including the development of challenge-based learning approaches, and contributes expertise in vascular flow modelling and thrombosis research.

UTBV is a public Romanian research university with broad expertise in automation, information technology, and AI, with a wide research track record in digital technologies and data science.

UTBV leads the development of AI-based tools for integrating multi-scale modelling, helping to connect cellular, thrombus, and circulation-level models into a unified predictive framework.

SANO is an international research centre dedicated to computational medicine and high-performance computing for healthcare applications. The centre develops advanced computational tools and data infrastructures for personalised medicine and biomedical research.

SANO contributes expertise in large-scale data processing and high-performance computing, supporting the analysis of complex datasets for AI training.

LEEDS is a globally recognised research university with strong expertise in cardiovascular science and thrombosis research. Its School of Medicine hosts leading groups investigating blood clot structure, platelet biology, and thrombus mechanics.

LEEDS focuses on thrombus-level modelling, investigating how blood clots grow, contract, rupture, and dissolve, thereby linking cellular processes to larger-scale thrombosis dynamics.

The University of Bern is a Swiss research university with significant expertise in biomedical engineering, cardiovascular modelling, and medical imaging. Through its collaboration with Inselspital Bern University Hospital, the university integrates engineering, clinical research, and advanced imaging technologies to study cardiovascular diseases.

UBERN supervises several doctoral candidates and contributes to computational modelling and cardiovascular research within the project. The university provides research infrastructure and clinical imaging expertise to support the development and validation of thrombosis models.

Amsterdam UMC is one of Europe’s largest academic medical centres, combining clinical care, biomedical research, and medical education. It conducts research programmes in cardiovascular medicine, vascular biology, and stroke research, supported by advanced laboratory and imaging facilities.

AMC provides laboratory facilities and experimental expertise in acute ischaemic stroke research and multi-photon imaging models. Within the project, the centre supports the generation of experimental data and provides datasets to refine and validate computational models of thrombosis.

Siemens Srl is part of Siemens Healthineers, a global leader in medical technologies and digital healthcare solutions. The company develops advanced diagnostic systems, medical imaging technologies, and data-driven healthcare platforms supporting precision medicine.

Within the project, Siemens provides industrial expertise in artificial intelligence and data-driven modelling. The company leads training in AI methods, data integration, and model development, while also offering industry perspectives to support the translation of research outcomes into innovative healthcare technologies.

CorFlow Therapeutics is a clinical-stage medical technology company focused on developing innovative diagnostic tools for coronary microvascular disease. The company operates at the intersection of cardiovascular research, medical device development, and translational medicine.

CorFlow provides expertise in cardiovascular diagnostics and microcirculation technologies. Within the project, the company supports research on microvascular obstruction and explores innovative approaches to targeted therapeutic delivery and thrombosis-related diagnostic technologies.

The University of Oxford is one of the world’s leading research universities, internationally recognised for excellence in biomedical sciences, clinical medicine, and translational research. Its Medical Sciences Division hosts leading research groups studying coagulation, thrombosis, and haemostasis.

OXF contributes specialised expertise in coagulation biology and thrombotic disorder management. The university participates in the training programme, hosts secondments, and supports the scientific development of doctoral candidates working on thrombosis-related research.

Maastricht University Medical Center+ is an academic hospital combining clinical care, biomedical research, and medical education. The centre hosts internationally recognised research groups working on thrombosis, vascular biology, and cardiovascular disease.

As an associated partner of Maastricht University, MUMC+ provides clinical expertise, patient data, and research infrastructure. The centre contributes to the training and supervision of doctoral candidates and supports the clinical validation of the project models.

The University of Sheffield is a research-intensive institution with internationally recognised expertise in computational modelling, cardiovascular physiology, and biomedical engineering. Through the Insigneo Institute for in silico Medicine, the university develops advanced computational methods to study human physiology and disease.

USFD provides expertise in cardiovascular physiology and predictive models of thrombus formation. Within the project, the university supports the development and validation of computational models to understand disease mechanisms and improve treatment strategies.

Catharina Hospital is a Dutch cardiovascular centre with strong expertise in vascular surgery, interventional cardiology, and clinical research. The hospital collaborates closely with academic institutions to support translational research and improve patient outcomes in cardiovascular diseases.

CZE offers clinical expertise in vascular surgery and cardiovascular imaging. Within the project, the hospital participates in the training programme and co-supervises doctoral candidates, helping to connect modelling approaches with clinical practice and patient care.

Lynkeus is an independent strategy and business consultancy founded in 2001, specialised in the design, management and exploitation of EU-funded projects in eHealth, artificial intelligence, advanced analytics and biomedical data platforms. Its multidisciplinary team of IT and biomedical scientists, project managers, legal experts and science communicators works at the intersection of ethics, law and medical technologies.

Within ThromboRisk, Lynkeus serves as the dissemination manager, supporting the beneficiaries in their dissemination, communication and exploitation obligations and contributing to achieving the project’s expected impacts.